DNA methylation profiling in nonfunctioning pituitary adenomas

Publication date: Available online 1 February 2018
Source:Molecular and Cellular Endocrinology
Author(s): Paulina Kober, Joanna Zbijewska, Nataliia Rusetska, Maria Maksymowicz, Krzysztof Goryca, Jacek Kunicki, Wiesław Bonicki, Janusz Aleksander Siedlecki, Mateusz Bujko
Nonfunctioning pituitary adenomas (NFPAs) are among the most frequent intracranial tumors but their molecular background, including changes in epigenetic regulation, remains poorly understood.We performed genome-wide DNA methylation profiling of 34 NFPAs and normal pituitary samples. Methylation status of the selected genomic regions and expression level of corresponding genes were assessed in a group of 75 patients.NFPAs exhibited distinct global methylation profile as compared to normal pituitary. Aberrant DNA methylation appears to contribute to deregulation of the cancer-related pathways as shown by preliminary functional analysis. Promoter hypermethylation and decreased expression level of SFN, STAT5A, DUSP1, PTPRE and FGFR2 was confirmed in the enlarged group of NFPAs. Difference in the methylation profiles between invasive and non-invasive NFPAs is very slight. Nevertheless, invasiveness-related aberrant epigenetic deregulation of the particular genes was found including upregulation of ITPKB and downregulation CNKSR1 in invasive tumors.



http://ift.tt/2nAzEqf